UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015536
Receipt number R000018049
Scientific Title A Pilot Trial of Telemedicine for Parkinson's Disease
Date of disclosure of the study information 2014/10/28
Last modified on 2020/01/29 21:36:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Pilot Trial of Telemedicine for Parkinson's Disease

Acronym

PD-Telemedicine

Scientific Title

A Pilot Trial of Telemedicine for Parkinson's Disease

Scientific Title:Acronym

PD-Telemedicine

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the impact of telemedicine system utilizing tablet mobile on quality of life of patient with Parkinson's disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The Parkinson's Disease Questionnaire (PDQ-39)

Key secondary outcomes

1. Unified Parkinoson's Disease Rating Scale (UPDRS) part I-IV
2. Modified Hoehn & Yahr scale
3. Beck Depression Inventory (BDI)
4. Questionnaires for participants


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Interview utilizing Tablet.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients with Parkinson's disease.
2. Age with 20-75.
3. Patients who can sign an informed consent form by him- or her-self.
4. Patients who can use iPad mini and have WiFi network environment.

Key exclusion criteria

1. Patients who connot sign an informed consent form by him- or her- self.
2. Patients who are regarded to inappropriate participant by researchers.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Genko Oyama

Organization

Juntendo University School of Medicine

Division name

Department of Neurology

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Email

g_oyama@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Genko Oyama

Organization

Juntendo University School of Medicine

Division name

Department of Neurology

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Homepage URL


Email

g_oyama@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Japan Foundation for Neuroscience and Mental Health

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院


Other administrative information

Date of disclosure of the study information

2014 Year 10 Month 28 Day


Related information

URL releasing protocol

https://www.hindawi.com/journals/pd/2019/9403295/

Publication of results

Published


Result

URL related to results and publications

https://www.hindawi.com/journals/pd/2019/9403295/

Number of participants that the trial has enrolled

10

Results

We observed that a telemedicine system delivered via a tablet could successfully be used by patients with Parkinson's Disease as a part of their care.

Results date posted

2020 Year 01 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients with Parkinson's Disease

Participant flow

Patients were randomized to receive either the telemedicine period followed by the control period, or the control period followed by the telemedicine period, with both periods lasting 6 months.

Adverse events

no

Outcome measures

1) Primary outcome
The Parkinson's Disease Questionnaire (PDQ-39)
2) Secondary outcomes
[1] Unified Parkinoson's Disease Rating Scale (UPDRS) part I-IV
[2] Modified Hoehn & Yahr staging scale
[3] Beck Depression Inventory (BDI)
[4] The Parkinson's Disease Questionnaire

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 24 Day

Date of IRB

2014 Year 10 Month 24 Day

Anticipated trial start date

2014 Year 11 Month 01 Day

Last follow-up date

2014 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 12 Month 31 Day

Date trial data considered complete

2014 Year 12 Month 31 Day

Date analysis concluded

2016 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 10 Month 27 Day

Last modified on

2020 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018049


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name